We have confirmed that knockdown of GOLPH3 inhibits the activation of the NF-κB pathway in glioma cells and the relationship between GOLPH3 and NF-κB pathway is consistent in glioma and HCC. This evidence concerns the gene NFKB1 and central nervous system cancer.